BW
ETRM

Bison Wealth’s EnteroMedics Inc. ETRM Stock Holding History

Bison Wealth’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20
Closed -$5K – 259
2015
Q3 		$5K Hold
20
– – ﹤0.01% 220
2015
Q2 		$13K Hold
20
– – 0.01% 248
2015
Q1 		$19K Hold
20
– – 0.01% 226
2014
Q4 		$30K Buy
+20
New +$27K 0.02% 196

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bison Wealth's ETRM Position: Q4 2015 in Review

Bison Wealth sold out of EnteroMedics Inc. (ETRM) in Q4 2015, closing a stake of 20 shares — an estimated $5K sold.

Bison Wealth first reported a position in ETRM in Q4 2014 and held it in 4 quarters. The position peaked at $30K in Q4 2014. 33 funds tracked by Wall St. Rank hold ETRM as of Q4 2015.

  • Bison Wealth reported no remaining EnteroMedics Inc. position as of Q4 2015 after selling out during the quarter.
  • Bison Wealth sold 20 EnteroMedics Inc. shares in Q4 2015, an estimated $5K.
  • Bison Wealth first reported a position in EnteroMedics Inc. in Q4 2014 and held it in 4 quarters.
  • Bison Wealth's EnteroMedics Inc. position peaked at $30K in Q4 2014.
  • 33 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2015.

Based on Bison Wealth's 13F filing for Q4 2015, filed 16 Feb 2016.